Regression of hepatocellular carcinoma due to cyclooxygenase (COX)-2 inhibitor

Am J Gastroenterol. 2006 Oct;101(10):2437-8. doi: 10.1111/j.1572-0241.2006.00742_6.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / pathology*
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / pathology*
  • Meloxicam
  • Thiazines / therapeutic use*
  • Thiazoles / therapeutic use*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Thiazines
  • Thiazoles
  • Meloxicam